These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22659694)

  • 1. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
    Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
    Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
    de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
    J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
    Chatterjee K; Williamson AL; Hoffman M; Dandara C
    J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
    Zhang F; Yang Y; Guo C; Wang Y
    Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.
    Catucci I; Verderio P; Pizzamiglio S; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Ripamonti CB; Pasini B; Barile M; Viel A; Giannini G; Papi L; Varesco L; Martayan A; Riboni M; Volorio S; Radice P; Peterlongo P
    Breast Cancer Res Treat; 2011 Feb; 125(3):855-60. PubMed ID: 20652397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
    Ji GH; Li M; Cui Y; Wang JF
    Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancer.
    Eskandari-Nasab E; Hashemi M; Hasani SS; Omrani M; Taheri M; Mashhadi MA
    Cancer Biomark; 2013; 13(4):253-9. PubMed ID: 24240586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
    Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
    BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
    Li Z; Wang J; Wang F; Ma Z; Yu Z
    Neth J Med; 2014 Jan; 72(1):10-6. PubMed ID: 24457433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
    Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B
    Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
    PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
    Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
    Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases.
    De Vecchi G; Verderio P; Pizzamiglio S; Manoukian S; Barile M; Fortuzzi S; Ravagnani F; Pierotti MA; Radice P; Peterlongo P
    Breast Cancer Res Treat; 2009 Feb; 113(3):607-8. PubMed ID: 18343995
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
    Liamarkopoulos E; Gazouli M; Aravantinos G; Tzanakis N; Theodoropoulos G; Rizos S; Nikiteas N
    Gastric Cancer; 2011 Oct; 14(4):317-21. PubMed ID: 21461653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with risk of coal workers' pneumoconiosis.
    Ni C; Ye Y; Wang M; Qian H; Song Z; Jia X; Zhou J
    J Toxicol Environ Health A; 2009; 72(11-12):712-6. PubMed ID: 19492233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
    Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
    Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping of -374A/T, -429A/G, and 63 bp Ins/del polymorphisms of RAGE by rapid one-step hexaprimer amplification refractory mutation system polymerase chain reaction in breast cancer patients.
    Hashemi M; Moazeni-Roodi A; Arbabi F; Fazaeli A; Nasab EE; Taheri M; Kerkhoff C; Ghavami S
    Nucleosides Nucleotides Nucleic Acids; 2012 May; 31(5):401-10. PubMed ID: 22497255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.